Skip to main content

Find Clinical Trials

Home
Conditions
Pityriasis

Clinical trial condition

Pityriasis

Explore clinical trials studying Pityriasis. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Pityriasis trial results

Not Yet Recruiting

Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP

NCT07497620

Conditions: Pityriasis, Pityriasis Rubra Pilaris, Skin Diseases, +2 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Not Yet Recruiting

Interleukin-4 in Pityriasis Lichenoides Chronica

NCT06889506

Conditions: Lichenoid Eruptions, Parapsoriasis, Pityriasis, +4 more
Locations: Not specified

View Trial Details

Completed

Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris

NCT06444399

Conditions: Pityriasis, Pityriasis Rubra Pilaris, Skin Diseases, +2 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

NCT03975153

Conditions: Pityriasis, Pityriasis Rubra Pilaris, Skin Diseases, +2 more
Locations: Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris

NCT03342573

Conditions: Pityriasis, Pityriasis Rubra Pilaris, Skin Diseases, +2 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Completed

Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).

NCT05094687

Conditions: Bacterial Infections and Mycoses, Blood Coagulation Disorders, COVID-19, +72 more
Locations: Jinnah Postgraduate Medical Centre Karachi, Sindh, Pakistan

View Trial Details

Completed

Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

NCT03485976

Conditions: Pityriasis, Pityriasis Rubra Pilaris, Skin Diseases, +2 more
Locations: Oregon Health and Science University Portland, Oregon, United States

View Trial Details